Other than the uncontrolled VA report on the last-stage already incubated patients. Please link all the others(plural), with negative outcome that you say you’ve seen, for us to read ourselves. Thanks.
Did you watch that video that Mat200 posted by that Doctor who researched the HCQ cardiac issue? It’s so insignificant as to be almost nil.
The one with the most data so far that I have seen is this one, which I posted on April 15 in post 2787:
In short, very sick patients in France. I think 181 total patients, split into HQ cohort and standard of care cohort. No clinical benefit from HQ, about 10% of patients had to be removed from the HQ therapy due to cardiac issues.
There was another one I posted a week or two before that, but I discounted it because it was very few patients (maybe a dozen). Someone with better search skills than me might find it (I did a quick scan of "my content" without quickly identifying it; I had provided the link in my post at the time. It was similar no benefit from HQ. I referred to it on April 8 (post 2535) so I know it was before that. I invite you to look for it but don't have time.
There was also a misinterpreted survey that made the rounds maybe a month ago or a bit less, I didn't save the link but it is in this thread somewhere (I didn't post it and don't have it handy--on a PDF with lots of purple and maybe green as I remember? ring any bells?) where a bunch of doctors were surveyed about what they felt the best treatment was going to be. HQ led the pack, but just barely more than "no treatment" and "standard of care" and the survey data were taken from a time when HQ was all the buzz. No actual patient data or differential outcomes were cited; the survey just said a bunch of doctors thought HQ would wind up being the best thing. This was misinterpreted to mean that these doctors were both actively using the drug and getting favorable results.
Also there are a lot of controlled studies going on that might show a benefit, even if some early ones don't. As I've said, cheap and easy treatment, I'm in.
Here is a trial for using HQ in early stage COVID-19, enrolling now I think:
clinicaltrials.gov
Hopefully this will show effectiveness.
Look, I'm a data guy. I follow the statistics to make decisions. I have no political agenda regarding HQ effectiveness.
There is one "not data yet" thing that makes me seriously question HQ effectiveness:
Lots of people around the world are trying it. Studies that show a strong positive signal versus other treatments will routinely switch more people into the treatment arm if it seems to be the right thing to do for the patient. I haven't heard of this happening at all. If HQ were so great, I think we would have heard about it by now, with tens of thousands of data points. Forget the US political angle, in Europe and Asia they don't care what Trump said. If the treatment were that effective, everyone and their brother would be telling us. The fact that I'm not hearing this leads me to believe any positive signal from HQ is small.
Oh, a PS: I'll be less active here for a few days due to work and personal issues; don't worry I will pester you with my liberal views later in the week.